A detailed history of Lmr Partners LLP transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 51,111 shares of VOR stock, worth $44,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,111
Previous 51,111 -0.0%
Holding current value
$44,466
Previous $51,000 31.37%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.0 - $2.2 $10,214 - $22,470
10,214 Added 24.97%
51,111 $51,000
Q1 2024

May 15, 2024

SELL
$1.8 - $2.85 $18,385 - $29,109
-10,214 Reduced 19.98%
40,897 $96,000
Q4 2023

Feb 14, 2024

BUY
$1.66 - $2.63 $3,869 - $6,130
2,331 Added 4.78%
51,111 $114,000
Q2 2023

Aug 14, 2023

SELL
$3.09 - $5.33 $35,590 - $61,390
-11,518 Reduced 19.1%
48,780 $150,000
Q1 2023

May 15, 2023

BUY
$4.68 - $6.96 $80,177 - $119,238
17,132 Added 39.69%
60,298 $324,000
Q4 2022

Feb 14, 2023

BUY
$3.77 - $7.43 $61,820 - $121,837
16,398 Added 61.26%
43,166 $287,000
Q2 2022

Aug 15, 2022

BUY
$3.89 - $6.44 $26,327 - $43,585
6,768 Added 33.84%
26,768 $133,000
Q1 2022

May 16, 2022

BUY
$6.04 - $12.23 $120,800 - $244,600
20,000 New
20,000 $121,000

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $33.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.